Novo Nordisk has decided to establish a type 1 diabetes research and development center in Seattle, Washington.
The unique concept behind the new center is to pursue a translational research approach characterized by combining basic research...
Even if you didn't have diabetes you wouldn't eat ice cream for breakfast, right? But when it comes to carbs, many of America's common, quick breakfast foods - the ones we've been taught are healthy - are bigger carb offenders than ice cream. A serving of Ben and Jerry's vanilla ice cream has 23 grams of carb.
The FDA has issued a complete response letter regarding the New Drug Application (NDA) for investigational compound dapagliflozin for the treatment of type 2 diabetes in adults submitted by Bristol-Myers Squibb Company and AstraZeneca...
After days of rumors regarding Paula Deen's diabetes diagnosis, the woman dubbed the Queen of Southern Cuisine has announced that she and her sons have partnered up with Novo Nordisk to launch Diabetes in a New Light™, a national initiative to help adults find simple ways...
KalVista Pharmaceuticals (“KalVista”) and JDRF have formed a research partnership focused on a novel approach being developed by KalVista to preserve vision and slow the progression of diabetic eye disease. Diabetic eye disease is one of the most common and most serious complications in people with type 1 diabetes (T1D). JDRF will provide up to $2.2 million inmilestone-based financial support and research expertise...
Medtronic announced the U.S. market launch of the first-of-its-kind mySentry™ Remote Glucose Monitor, which allows a parent or caregiver to monitor from another room a patient’s MiniMed Paradigm® REAL-Time Revel™ System. The remote glucose monitor also marks the launch of a new category of Connected Care solutions that will provide...
Medtronic announced the U.S. market launch of the first-of-its-kind mySentry™ Remote Glucose Monitor, which allows a parent or caregiver to monitor from another room a patient’s MiniMed Paradigm® REAL-Time Revel™ System. The remote glucose monitor also marks the launch of a new category of Connected Care solutions that will provide...
One year after Osiris Therapeutics in partnership with JDRF started the Phase 2 trial evaluating Prochymal, a formulation of adult mesenchymal stem cells (MSCs), in newly diagnosed type 1 diabetes patients, the company has released a statement providing an update on this groundbreaking trial. This first-of-its kind trial is...
Since its recent commercial launch, the Spring Universal Infusion Set has been particularly well received by parents of children with type 1 diabetes. Specifically, the following features were highly favored: the automatic all-in-one inserter (which gives young patients the independence to do their own site changes), the lightning-fast needle insertion...
Researchers from the John Curtin School of Medical Research in Canberra, Australia have discovered that the insulin-producing beta cells need a complex sugar, heparan sulfate, for their survival and without it they die. Replacement of heparan sulfate in the beta cells rescues the cells from dying in culture and protects them from oxidative damage...